IT department seizes ₹143 crore from Hyderabad-based pharma group

Unaccounted income worth ₹550 crore detected

October 10, 2021 01:45 am | Updated 01:45 am IST - NEW DELHI

The Income-Tax Department searches on a major Hyderabad-based pharmaceutical group has lead to the seizure of about ₹143 crore in cash and detection of unaccounted income to the tune of ₹550 crore.

The agency started the search and seizure operations on October 6 and about 50 locations across six States were covered.

“This pharmaceutical group is engaged in the business of manufacturing of intermediates, Active Pharmaceutical Ingredients (APIs) and formulations. Majority of the products are exported to foreign countries i.e. U.S.A, Europe, Dubai and other African countries,” the Department said.

During the searches, the agency identified the hideouts where a second set of books-of-accounts and cash had been stored. Evidence in the form of digital media, pen drives and documents were seized. “Incriminating digital evidence was gathered from SAP @ ERP software maintained by the assessee group,” it said.

The agency detected several issues related to discrepancies in the purchases made from bogus and non-existent entities, and artificial inflation of certain heads of expenditure.

“Further, evidence of on-money payment for purchase of lands was also found. Various other legal issues were also identified...,” the agency said, adding that personal expenses were included in the company’s books. Land was purchased by the related parties below the government registration value.

According to the I-T Department, several bank lockers — 16 of which have been operated — were located during the searches.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.